Adam Levy
Investor Relations Contact chez ALAUNOS THERAPEUTICS, INC.
Postes actifs de Adam Levy
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ALAUNOS THERAPEUTICS, INC. | Investor Relations Contact | 01/11/2020 | - |
| Public Communications Contact | 01/11/2020 | 30/08/2021 | |
| TURG POIN | Investor Relations Contact | 08/11/2021 | - |
| Public Communications Contact | 08/11/2021 | - | |
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | - | - |
| ACRIVON THERAPEUTICS, INC. | Investor Relations Contact | 20/07/2023 | - |
Vesselon, Inc.
 Vesselon, Inc. Medical SpecialtiesHealth Technology Vesselon, Inc. develops a portable ultrasound medical device for treating neurodegenerative diseases and brain & ischemic strokes. It commercializes a drug delivery platform that combines ultrasound and microbubbles to deliver the drugs across tissue barriers directly into a target without the need to modify the drug through a process, microbubble assisted sono-therapy. The company was founded by Clayton T. Larsen and Rhodemann Li in 2012 and is headquartered in Norwalk, CT. | Director/Board Member | - | - |
Historique de carrière de Adam Levy
Anciens postes connus de Adam Levy
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ZENTALIS PHARMACEUTICALS, INC. | Investor Relations Contact | - | - |
Formation de Adam Levy
| University of Illinois | Doctorate Degree |
| Kellogg School of Management | Masters Business Admin |
Statistiques
Internationale
| Etats-Unis | 9 |
Opérationnelle
| Investor Relations Contact | 4 |
| Public Communications Contact | 2 |
| Director/Board Member | 1 |
Sectorielle
| Health Technology | 7 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| GILEAD SCIENCES, INC. | Health Technology |
| ALAUNOS THERAPEUTICS, INC. | Health Technology |
| ZENTALIS PHARMACEUTICALS, INC. | Health Technology |
| ACRIVON THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Turning Point Therapeutics, Inc.
 Turning Point Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Turning Point Therapeutics, Inc. is a clinical-stage oncology biopharmaceutical company, which engages in designing and developing next-generation therapies that target genetic drivers of cancer to improve the lives of patients. Its product pipeline include Repotrectinib, TPX-0022, TPX-0046, and TPS-O131, a next-gen ALK inhibitor. The company was founded by Jingrong Jean Cui and Y. Peter Li in October 2013 and is headquartered in San Diego, CA. | Health Technology |
Vesselon, Inc.
Vesselon, Inc. Medical SpecialtiesHealth Technology Vesselon, Inc. develops a portable ultrasound medical device for treating neurodegenerative diseases and brain & ischemic strokes. It commercializes a drug delivery platform that combines ultrasound and microbubbles to deliver the drugs across tissue barriers directly into a target without the need to modify the drug through a process, microbubble assisted sono-therapy. The company was founded by Clayton T. Larsen and Rhodemann Li in 2012 and is headquartered in Norwalk, CT. | Health Technology |
